Lj. Ettinger et al., Long-term survival in an adolescent with widely metastatic renal cell carcinoma with rhabdoid features, J PED H ONC, 22(2), 2000, pp. 173-175
Renal cell carcinoma is rarely seen in children and adolescents. Patients w
ith widespread disease at diagnosis have a particularly poor survival rate.
Currently, all known chemotherapy has been ineffective in improving the me
dian survival in patients with advanced disease. A 13-year-old black boy wi
th stage IV renal cell carcinoma with rhabdoid features is a long-term dise
ase-free survivor after aggressive multiagent chemotherapy. After the initi
al evaluation and histologic diagnosis of renal cell carcinoma, the patient
received three courses of an aggressive chemotherapy regimen consisting of
vincristine, doxorubicin, cyclophosphamide with mesna uroprotection, granu
locyte colony-stimulating factor and erythropoietin (Epogen). After an almo
st complete response, a radical nephrectomy was performed and results demon
strated a solitary small nodule with viable tumor. After surgery, he receiv
ed floxuridine infusion for 14 days by circadian schedule at 28-day interva
ls for a total of 1 year. The patient is well and free of disease 5 years a
fter initial presentation. The dramatic response to treatment and long-term
disease-free survival of this patient suggest this chemotherapeutic approa
ch warrants additional investigation.